A number of factors point to the likelihood of a person with RA developing RV:

Similar documents
CENTRAL NERVOUS SYSTEM VASCULITIS

GIANT CELL ARTERITIS. Page 1 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.

GRANULOMATOSIS WITH POLYANGIITIS

KAWASAKI DISEASE. What is Kawasaki disease? Causes

TAKAYASU S ARTERITIS. Second-stage symptoms include:

RARE JUVENILE PRIMARY SYSTEMIC VASCULITIS

GPA & MPA GRANULOMATOSIS WITH POLYANGIITIS &MICROSCOPIC POLYANGIITIS. What you need to know about GPA & MPA

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

Vasculitis. Edward Dwyer, M.D. Division of Rheumatology. Vasculitis

Polymyalgia rheumatica and giant cell arteritis

Mohammad Reza Shakibi M.D Kerman university of medical sciences (KMU) Shafa Hospital, Rheumatology ward

Atlas of the Vasculitic Syndromes

Lupus. Fast facts. What is lupus? What causes lupus? Who gets lupus?

ARTHRITIS FOUNDATION VASCULITIS

Case Presentation VASCULITIS. Case Presentation. Case Presentation. Vasculitis

PAEDIATRIC VASCULITIS

VASCULITIS. Case Presentation. Case Presentation

Definition Chronic autoimmune disease The body s immune system starts attacking itself Can affect most organs and tissues in the body Brain, lungs, he

ANCA associated vasculitis in China

Inflammatory Bowel Diseases Clinic

Vasculitis local: systemic

Inflectra for Crohn s disease

UNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS

13. Behçet s - In Children

Index. Note: Page numbers of article titles are in boldface type.


How Is Lupus Diagnosed?

The exact cause of sarcoidosis is unknown. However, gender, race, and genetics can increase the risk of developing the condition:

Vasculitis local: systemic

Scleritis LEN V KOH OD

Familial Mediterranean Fever

VASCULITIC SYNDROMES. Howard L. Feinberg, D.O., F.A.C.O.I., F.A.C.R. OPSC 2018

What you should know about Truxima (rituximab)

JUST FOR KIDS SELECTED IMPORTANT SAFETY INFORMATION

UNDERSTANDING CROHN S DISEASE

The London Gastroenterology Partnership CROHN S DISEASE

Financial Report. Moving Together

REFERRAL GUIDELINES: RHEUMATOLOGY

Interstitial Lung Disease

Understanding Adalimumab

Myositis and Your Lungs

We will review the need for continuing treatment with you after 3 months and again after one year.

AKI Case study -Vasculitis. Sarah Mackie Renal Practice Development Nurse King s College Hospital - London

FAQ Identifying and enrolling participants

Sarcoidosis. Sarcoidosis Care at National Jewish Health. Causes

Use of steroids in neurological conditions. Information for patients Pharmacy

Abatacept. What is abatacept?

Drug information. Tofacitinib TOFACITINIB. is used to treat rheumatoid arthritis and psoriatic arthritis. Helpline

Annual Rheumatology & Therapeutics Review for Organizations & Societies

Informed Consent for Liver Transplant Patients

Esophageal Cancer. Source: National Cancer Institute

SMALL TO MEDIUM VASCULITIS: RENAL ASPECT RATANA CHAWANASUNTORAPOJ UPDATE IN INTERNAL MEDICINE 2018

Pain or stiffness in joints after periods of inactivity or excessive use

What is ulcerative colitis?

Pharmacy Management Drug Policy

WHAT IS ULCERATIVE COLITIS?

Systemic Lupus Erythematosus

Table S1. Read and ICD 10 diagnosis codes for polymyalgia rheumatica and giant cell arteritis

Upper gastrointestinal endoscopy and colonoscopy

Introduction What Causes Peripheral Vascular Disease? How Do Doctors Treat Peripheral Vascular Disease?... 9

Learning about Lupus. Learning About Lupus. Lupus Society of Illinois

Tell me more about vasculitis. Lisa Willcocks Consultant in Nephrology and Vasculitis, Addenbrooke s Hospital

Understanding Rheumatoid Arthritis

Large granular lymphocytic leukaemia (LGLL)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] Mepolizumab for Injection

Certain genes passed on from parent to child increase the risk of developing Crohn's disease, if the right trigger occurs.

INITIAL PAIN EVALUTION QUESTIONNAIRE

Diagnostic Procedures for Vasculitis

Rheumatoid Arthritis

Multiple Sclerosis. What is multiple sclerosis? What is the cause? What are the symptoms?

NEW PATIENT QUESTIONNAIRE For Dr Benoy Benny. Section 1: Today s Date: Date of Birth: Age:

Professor Michael Kossove

The Vasculitis Syndromes

How Is Scleroderma Treated?

Summary Article: Lupus (Systemic Lupus Erythematosus) from Harvard Medical School Health Topics A-Z

Screening tests. When you need them and when you don t

Vasculitis and Vasculitides. OMONDI OYOO Physician/Rheumatologist; Senior Lecturer, Department of Medicine University of Nairobi

What is an Upper GI Endoscopy?

National Digestive Diseases Information Clearinghouse

Underwriting Helpful Hints

Autoimmune Liver Disease

MEDICATIONS: THE GOOD, THE BAD, THE UGLY

Management of Acute Vasculitis. CMT teaching 3 rd June 2015 Caroline Wroe

SARAH VLACH, MD TYLER HEDIN, MD JUDY GOOCH, MD

ONE PILL, ONCE A DAY GET TO KNOW AUBAGIO. Ask your doctor if AUBAGIO may be right for you. Patient Portrayal

December 6, 2010 Asthma and Rheumatic Disorders and Vasculitis

Iowa Methodist Medical Center Transplant Center. Informed Consent for Kidney Transplant Recipient

YOUR GUIDE TO TECENTRIQ (atezolizumab) non-small cell lung cancer (NSCLC)

Abatacept Drug information. Abatacept is used to treat rheumatoid arthritis.

Olumiant (baricitinib) tablets

MULTIPLE SCLEROSIS INTRODUCTION OBJECTIVES. When the student has finished this module, he/she will be able to:

Cancer of the oropharynx

LIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

If your IBD has not been well controlled, or is flaring up quite often, methotrexate may be added to your treatment.

Golimumab (Simponi ) Therapy

What Is Peptic Ulcer Disease?

Parathyroidectomy. Surgery for Parathyroid Problems

Important safety information to minimise the risk of immune-related adverse reactions

THE ENDOCRINE SYSTEM Station 1 (A)

Transcription:

What is rheumatoid vasculitis (RV)? Rheumatoid vasculitis (RV) is a rare but serious complication of rheumatoid arthritis (RA) an inflammatory disease that causes severe joint pain and damage, and can move beyond the joints to other parts of the body. When RA affects the blood vessels, it is called rheumatoid vasculitis. RV causes inflammation and narrowing of the small- and medium-sized blood vessels, and most commonly affects the skin, nerves, fingers, and toes. However, it can involve virtually any organ in the body. People with RA who smoke may have a higher risk of developing this complication. The primary symptoms of RV include skin rash; small pits on the fingertips or sores and redness around the nail; and numbness, tingling, and pain of the hands and feet. Because RV is systemic (affecting the whole body), it can also affect the heart, kidneys, gastrointestinal tract (GI), brain or lungs. RV resembles other forms of vasculitis, including polyarteritis nodosa and cryoglobulinemia. With early diagnosis and treatment, it is possible to control symptoms of RV and prevent or minimize organ damage. Treatment depends on disease severity and involvement of other organs. Mild disease affecting the skin and nerves is typically treated with corticosteroids such as prednisone, and/or medications that suppress the immune system. More serious organ involvement may require higher doses of steroids, or other powerful agents that control inflammation. Treatment decisions should take into account the underlying RA. Drugs taken for RA may improve both arthritis and vasculitis symptoms. Even with effective treatment, RV and RA are chronic diseases, so ongoing medical care is necessary. Causes The cause of RV is not fully understood by researchers. Vasculitis is classified as an autoimmune disorder, a disease which occurs when the body s natural defense system mistakenly attacks healthy tissue. Researchers believe a combination of factors may set the inflammatory process in motion, including genetics, drug reactions, or an infection or virus. A number of factors point to the likelihood of a person with RA developing RV: Long-standing, severe RA, for 10 or more years High concentrations of rheumatoid factor antibodies, and the levels of certain other proteins in the blood Felty s syndrome, a complication of RA characterized by an enlarged spleen and an abnormally low white cell count The presence of rheumatoid nodules, firm lumps under the skin around the joints of RA patients Smoking cigarettes, which may damage the lining of the blood vessels and predispose people to developing RV Who gets rheumatoid vasculitis? RV is rare, occurring in less than 1 percent of those who have RA, while RA is considered common and affects millions of people annually. It is estimated that 400 people per million develop RA per year, Page 1 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.

compared to fewer than 4 people per million who develop RV. It appears that men are more likely to develop RV than women, and it can affect people from any ethnic background. Symptoms RV mostly affects the skin, peripheral nerves, and the fingers and toes, but it can affect any organ and cause numerous symptoms. General symptoms of RV include fever, fatigue, loss of appetite and weight loss, which are common symptoms of RA as well. Other symptoms include: Small pits in the fingertips, sores/ulcers around the fingernails A painful red rash, especially on the legs, or purplish bruises Tissue death (necrosis) of the fingers and toes if blood flow becomes totally blocked Numbness, tingling and pain, especially in the fingers and toes Muscle weakness Chest pain Abdominal pain Complications Although it is uncommon, serious, even life-threatening, complications can occur if RV affects major organs such as the heart, kidneys, lungs, GI tract or brain. These include: Heart attack Stroke Kidney failure Restriction of blood supply to the bowels Atherosclerosis Diagnosis There is no single test to diagnose RV. Your doctor will consider a number of factors, including a detailed medical history; physical examination; laboratory tests (blood/urine); and specialized imaging studies. A tissue biopsy is typically required to make a definitive diagnosis. Your doctor may suspect RV based on the characteristic symptoms of rash, numbness and tingling of the extremities, skin ulcers, chest pain or other symptoms. Diagnosis also involves ruling out diseases that cause similar symptoms, including other forms of vasculitis (polyarteritis nodosa and cryoglobulinemia); diabetes; and atherosclerosis, which can also cause narrowing of blood vessels. Depending on organs affected, the following diagnostic tests, or others, may be ordered: Blood tests: To detect abnormal levels of antibodies and proteins in the blood, which can indicate inflammation. People with RV typically have elevated levels of rheumatoid factor antibodies, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR, or sed rate ). Imaging: Chest X-ray; computed tomography (CT) or magnetic resonance imaging (MRI) scans of brain, chest or abdomen; angiogram (X-ray of blood vessel after injection of contrast dye) Electrocardiogram (ECG): To check heart rhythm Page 2 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.

Endoscopy: An examination of the esophagus, stomach and portions of the intestine with a lighted, flexible instrument called an endoscope Nerve conduction (EMG): To test nerve function Tissue biopsy (usually required to confirm the diagnosis): This surgical procedure removes a small tissue sample from an affected vessel (skin ulcer, nerve or muscle), which is examined under a microscope for signs of inflammation or tissue damage. Treatment The course of treatment for RV depends on the severity of vasculitis and organs involved. Any treatment decisions should take into account the underlying RA and how it is being treated. Drugs taken for RA may improve both joint symptoms and the vasculitis. For mild symptoms of RV, such as fingertip sores, treatment involves protecting the area to prevent infection and use of corticosteroids, such as prednisone. For more widespread disease, corticosteroids may be used in combination with immunosuppressants, such as methotrexate or azathioprine. More serious organ involvement may require higher doses of steroids, cyclophosphamide (a chemotherapytype drug), or biologic agents such as rituximab, abatacept, or others. Biologics are complex proteins derived from living organisms. They target certain parts of the immune system to control inflammation. Research has shown that RV is associated with smoking. If you have RA and are a smoker, stopping smoking may reduce the risk of developing RV. Side effects The medications used to treat RV and RA have potentially serious side effects, such as lowering the body s ability to fight infection, and potential bone loss (osteoporosis), among others. Therefore, it s important to see your doctor for regular checkups. Medications may be prescribed to offset side effects. Infection prevention is also very important. Talk to your doctor about getting a flu shot, pneumonia vaccination, and/or shingles vaccination, which can reduce your risk of infection. Relapse Even with effective treatment, relapses can occur with RV. If your symptoms return, or you develop new ones, report them to your doctor as soon as possible. Regular doctor visits and ongoing monitoring of lab and imaging tests are important in detecting relapses early. Your medical team Effective treatment of RV may require the coordinated efforts and ongoing care of a team of medical providers and specialists. In addition to a primary care provider, you may need to see the following specialists: rheumatologist (joints, muscles, immune system); dermatologist (skin); neurologist (nerves); ophthalmologist (eyes); gastroenterologist (digestive system); (cardiologist (heart); pulmonologist (lungs); or others as needed. The best way to manage your disease is to actively partner with your health care providers. Get to know the members of your health care team. It may be helpful to keep a health care journal to track your Page 3 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.

medications, symptoms, test results and notes from doctor appointments in one place. To get the most out of your doctor visits, make a list of questions beforehand and bring along a supportive friend or family member if necessary to provide a second set of ears and take notes. Remember, it s up to you to be your own advocate. If you have concerns with your treatment plan, be sure to speak with your medical team. Your doctor may be able to adjust your dosage or offer different treatment options. It is always your right to seek a second opinion. Living with rheumatoid vasculitis Living with a serious health condition such as RV can be overwhelming at times. Fatigue, pain, emotional stress, and medication side effects can take a toll on your sense of well-being, affecting relationships, work and other aspects of your daily life. Sharing your experience with family and friends, connecting with others through a support group, or talking with a mental health professional can help. Outlook Rheumatoid vasculitis is one of the most serious complications of long-standing RA, and prognosis depends on disease severity and organ involvement. Some patients have milder symptoms while others can develop serious complications including heart failure, kidney failure and stroke, among others. Early diagnosis and treatment are essential in controlling the disease and preventing damage to blood vessels, vital tissues and organs. Not smoking may reduce the risk of developing RV. The incidence of RV has decreased over the past 40 years due to improved RA treatments, including widespread use of biologic therapies. Clinical studies are ongoing at multicenter research centers, including the Vasculitis Clinical Research Consortium (VCRC), to better understand the risk factors and causes of vasculitis, investigate more effective and safer treatments, and work toward a cure. The Vasculitis Foundation encourages patients to consider participating in clinical research studies to help further understanding of vasculitis. Patients are also encouraged to join the Vasculitis Patient Powered Research Network (VPPRN), where they can provide valuable disease insight and information. For more information on vasculitis research, visit: www.vasculitisfoundation.org/research Page 4 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.

About Vasculitis Vasculitis is a family of nearly 20 rare diseases characterized by inflammation of the blood vessels, which can restrict blood flow and damage vital organs and tissues. Vasculitis is classified as an autoimmune disorder, which occurs when the body s natural defense system mistakenly attacks healthy tissues. Triggers may include infection, medication, genetic or environmental factors, allergic reactions, or another disease. However, the exact cause is often unknown. A Family of Diseases Anti-GBM (Goodpasture s) disease Aortitis Behcet s syndrome Central nervous system vasculitis Cogan s syndrome Cryoglobulinemia Cutaneous small-vessel vasculitis (formerly hypersensitivity/leukocytoclastic) Eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg-Strauss syndrome) Giant cell arteritis Granulomatosis with polyangiitis (GPA, formerly Wegener s) IgA vasculitis (Henoch-Schönlein Purpura) Kawasaki disease Microscopic polyangiitis Polyarteritis nodosa Polymyalgia rheumatica Rheumatoid vasculitis Takayasu s arteritis Urticarial vasculitis About the Vasculitis Foundation The Vasculitis Foundation (VF) is the leading organization in the world dedicated to diagnosing, treating, and curing all forms of vasculitis. The VF provides a wide range of education, awareness and research programs and services. To learn more, and get the most updated disease and treatment information, visit www.vasculitisfoundation.org Connect with the VF on Social Media Instagram: vasculitisfoundation Twitter: @VasculitisFound VF Facebook Discussion Group: www.facebook.com/groups/vasculitisfoundation Page 5 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.

Ways to Get Involved Participate in research Join social media Host or participate in an event Attend a regional conference and/or symposium Give a donation toward long-term solutions Become an advocate for yourself, or for others Share your journey Vasculitis Foundation Mission Building upon the collective strength of the vasculitis community, the Foundation supports, inspires and empowers individuals with vasculitis, and their families, through a wide range of education, research, clinical, and awareness initiatives. Join the VPPRN! The Vasculitis Patient-Powered Research Network (VPPRN) seeks to improve the care and health of patients with vasculitis by exploring research questions that matter most to patients, and by advancing medical knowledge about vasculitis. For more information, visit: www.vpprn.org The Vasculitis Clinical Research Consortium (VCRC) is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research in different forms of vasculitis. For more information, visit: www.rarediseasesnetwork.org/cms/vcrc Vasculitis Foundation PO Box 28660 Kansas City, Missouri, 64188-8660 USA Phone: 816.436.8211 Toll-free: 800.277.9474 Fax: 816.656.3838 www.vasculitisfoundation.org Email: vf@vasculitisfoundation.org The VF gratefully acknowledges Alexandra Villa-Forte, MD, MPH, Cleveland Clinic, for her expertise and contribution to this brochure. This brochure was supported by an unrestricted education grant from Genentech. The Vasculitis Foundation is solely responsible for all content. The Vasculitis Foundation (VF) is a 501(c)(3) nonprofit organization governed by a Board of Directors and advised on medical issues by a Medical and Scientific Advisory Board. VF s educational materials are not intended to replace the counsel of a physician. VF does not endorse any medications, products or treatments for vasculitis, and advises you to consult a physician before initiating any treatment. (Updated October 2018) Page 6 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.